TickerFacts.

Ensysce Biosciences, Inc. (ENSC): Total Liabilities

Annual figures by period end, from SEC filings.

$4.57M
As of 2025-12-31
$4.07M
As of 2026-06-30
-22.8%
3-year compound annual growth
-8.2%
5-year compound annual growth
$57.08M2017-12-31: $12.82M2018-03-31: $12.52M2018-06-30: $12.73M2018-09-30: $14.66M2018-12-31: $13.17M2019-03-31: $12.78M2019-06-30: $13.16M2019-09-30: $13.66M2019-12-31: $17.50M2020-03-31: $57.08M2020-06-30: $16.11M2020-09-30: $11.77M2020-12-31: $7.01M2021-12-31: $24.58M2022-12-31: $9.91M2023-12-31: $3.36M2024-12-31: $2.22M2025-12-31: $4.57M$4.57M
2017-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$4.57M+106.0%2026-03-30, Balance as of period end
2024-12-31$2.22M-34.0%2026-03-30, Balance as of period end
2023-12-31$3.36M-66.1%2025-03-10, Balance as of period end
2022-12-31$9.91M-59.7%2024-03-15, Balance as of period end
2021-12-31$24.58M+250.6%2023-03-30, Balance as of period end
2020-12-31$7.01Mn/a2022-03-31, Balance as of period end
2020-09-30$11.77Mn/a2021-06-08, Balance as of period end
2020-06-30$16.11Mn/a2021-06-08, Balance as of period end
2020-03-31$57.08Mn/a2021-06-08, Balance as of period end
2019-12-31$17.50Mn/a2021-06-08, Balance as of period end
2019-09-30$13.66Mn/a2021-06-08, Balance as of period end
2019-06-30$13.16Mn/a2021-06-08, Balance as of period end
2019-03-31$12.78Mn/a2021-06-08, Balance as of period end
2018-12-31$13.17Mn/a2021-06-08, Balance as of period end
2018-09-30$14.66Mn/a2021-06-08, Balance as of period end
2018-06-30$12.73Mn/a2021-06-08, Balance as of period end
2018-03-31$12.52Mn/a2021-06-08, Balance as of period end
2017-12-31$12.82Mn/a2021-06-08, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Ensysce Biosciences, Inc. (ENSC)2025-12-31$4.57M+106.0%
ProPhase Labs, Inc. (PRPH)2025-12-31$56.36M+0.9%
China Pharma Holdings, Inc. (CPHI)2025-12-31$8.26M+15.7%
Korro Bio, Inc. (KRRO)2025-12-31$62.07M-5.7%
CervoMed Inc. (CRVO)2025-12-31$4.66M+20.0%
Immunome Inc. (IMNM)2025-12-31$48.84M-17.3%
Whitehawk Therapeutics, Inc. (WHWK)2025-12-31$14.52M-18.6%
Marker Therapeutics, Inc. (MRKR)2025-12-31$2.27M-34.4%
Ovid Therapeutics Inc. (OVID)2025-12-31$20.27M-15.3%

Compare ENSC, PRPH, CPHI, KRRO side by side · Screen every company in Pharmaceutical Preparations ↗